tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
VRTX
Vertex Pharmaceuticals
RESEARCH TOOLSreports

Vertex Pharmaceuticals (VRTX) Stock News & Sentiment

Compare
6,581 Followers
Vertex Pharmaceuticals: Positive Risk-Reward on Emerging Renal Pipeline and Pove IgAN Phase 3 Catalyst Supports Buy Rating
Premium
Ratings
Vertex Pharmaceuticals: Positive Risk-Reward on Emerging Renal Pipeline and Pove IgAN Phase 3 Catalyst Supports Buy Rating
4d ago
VRTX
Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story
Premium
Company Announcements
Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story
26d ago
VRTX
Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26
Premium
Stock Analysis & Ideas
Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26
28d ago
CI
VRTX
BofA Rolls Out “Top 10 Ideas” for 1Q26 Across Key Sectors
Premium
Market News
BofA Rolls Out “Top 10 Ideas” for 1Q26 Across Key Sectors
1M ago
BA
CI
Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
Premium
Ratings
Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
1M ago
VRTX
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
Premium
Ratings
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
2M ago
VRTX
Vertex Pharmaceuticals: Promising Advancements in Kidney Disease Treatments Drive Buy Rating
Premium
Ratings
Vertex Pharmaceuticals: Promising Advancements in Kidney Disease Treatments Drive Buy Rating
2M ago
VRTX
More VRTX News >

VRTX News on the Web

Vertex (VRTX) Secures Exclusive Rights for Innovative Autoimmune Treatment
GuruFocus News
Bullish
Vertex Pharmaceuticals: Positive Risk-Reward on Emerging Renal Pipeline and Pove IgAN Phase 3 Catalyst Supports Buy Rating
TipRanks News
Bullish
Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays
TipRanks News
Bullish
Bank of America Securities Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Vertex Pharmaceuticals (VRTX) Receives a Buy from Citi
TipRanks News
Bullish
Vertex Pharmaceuticals price target raised to $545 from $535 at UBS
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (CORT), Intuitive Surgical (ISRG) and Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
VRTX
Sector Average
Media Buzz
This Week2 articles
Weekly Average8.75 articles
News Sentiment
This Week100%
Sector Average72%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRTX’s Media Buzz Sentiment?
2 articles about VRTX were published this week. In an average week, 8.75 articles are published.
    What is VRTX’s weekly average amount of articles?
    In an average week, 8.75 articles about VRTX are published.
      What is VRTX’s News Sentiment?
      100% of articles about VRTX were positive this week, compared to its sector average of 72%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        QNCXQuince Therapeutics
        VREOFVireo Growth
        KRROKorro Bio
        DVADaVita
        Showing the stocks with the most bullish news sentiment over the past week